Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CREB3L1 |
| Upstream (Parents) |
|---|
| (<<) TFAP2B → CREB3L1 |
| (<<) FOXC1 → CREB3L1 |
| (<<) TFCP2L1 → CREB3L1 |
| (<<) SPDEF → CREB3L1 |
| (<<) CREB3L4 → CREB3L1 |
| (<<) HOXB6 → CREB3L1 |
| (<<) ZNF165 → CREB3L1 |
| (<<) TAF4B → CREB3L1 |
| (<<) AEBP1 → CREB3L1 |
| (<<) MESP1 → CREB3L1 |
| (<<) L3MBTL4 → CREB3L1 |
| (<<) TCFL5 → CREB3L1 |
| (<<) HMG20B → CREB3L1 |
| (<<) HOXB5 → CREB3L1 |
| Downstream (Children) |
|---|
| CREB3L1 → PEG3 (>>) |
| CREB3L1 → ELF5 (>>) |
| CREB3L1 → SOX2 (>>) |
| CREB3L1 → MYCN (>>) |
| CREB3L1 → NFIB (>>) |
| CREB3L1 → WNT5A (>>) |
| CREB3L1 → MYC (>>) |
| CREB3L1 → DMRT2 (>>) |
| CREB3L1 → HOXB2 (>>) |
| CREB3L1 → MMP14 (>>) |
| CREB3L1 → RARA (>>) |
| CREB3L1 → IRF5 (>>) |
| CREB3L1 → TCF19 (>>) |
| CREB3L1 → C2orf3 (>>) |
| CREB3L1 → SLC2A4RG (>>) |
| CREB3L1 → BCL3 (>>) |
| CREB3L1 → GATAD2B (>>) |
| CREB3L1 → ZNF232 (>>) |
| CREB3L1 → HNF4G (>>) |
| CREB3L1 → PBX3 (>>) |
| CREB3L1 → HDAC2 (>>) |
